Molindone

This classification denotes an antipsychotic agent with the molecular formula C16H24N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RT3Y3QMF8N, chemically known as 4h-indol-4-one, 3-ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)- but generally known as molindone, which bears US NIH Compound Identifier 23897. European Medicines Agency schedules Molindone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09042MIG. The term MOLINDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules molindone in its Anatomical Therapeutic Chemical (ATC) Classification. MOLINDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule molindone under HS 29349990 and SITC 51579. As of Q4 2014, MOLINDONE remains the US FDA Preferred Term for this commodity. Molindone bears US NLM identifiers UMLS ID C0026388 and NCI Concept Code C61850. SMILES: O1CCN(CC2CCC3[NH]C(C(C3C2=O)CC)C)CC1.